Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

98.82
666,765

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical Services

Zacks News

Here's Why HealthEquity (HQY) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is Why Growth Investors Should Buy HealthEquity (HQY) Now

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Alignment HealthCare Partners With Intermountain Health in Nevada

ALHC partners with Intermountain Health to enhance access to high-quality care for Medicare members in Clark and Washoe counties, starting Jan 2025.

Why Is HealthEquity (HQY) Down 4.3% Since Last Earnings Report?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is HealthEquity Stock a Buy Now Amid Strength in HSAs?

HQY's strong quarterly results and solid top-line growth raise optimism about the stock.

Looking for a Growth Stock? 3 Reasons Why HealthEquity (HQY) is a Solid Choice

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Wall Street Analysts Think HealthEquity (HQY) Could Surge 32.88%: Read This Before Placing a Bet

The mean of analysts' price targets for HealthEquity (HQY) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks.com featured highlights include TAL Education, The RealReal, DarioHealth, HealthEquity and Energous

TAL Education, The RealReal, DarioHealth, HealthEquity and Energous have been highlighted in this Screen of The Week article.

Sanghamitra Saha headshot

Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains

Tap five stocks with increasing P/E ratios. These stocks include TAL Education Group (TAL), The RealReal (REAL), DarioHealth (DRIO), HealthEquity (HQY) and Energous (WATT).

Cigna's Health Benefits Unit Launches a New E-Treatment Option

CI's new launch, a new E-Treatment option, is expected to improve patient satisfaction and operational efficiency.

Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HQY vs. MEDP: Which Stock Is the Better Value Option?

HQY vs. MEDP: Which Stock Is the Better Value Option?

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HealthEquity Stock May Gain From Its Latest Partnership With Paytient

HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.

HealthEquity Stock Rises on Q2 Earnings and Revenue Beat

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

HealthEquity (HQY) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) Surpasses Q2 Earnings and Revenue Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of 22.86% and 5.43%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

The Cooper Companies (COO) Q3 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) delivered earnings and revenue surprises of 5.49% and 0.57%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?

What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q2 Earnings

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended July 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Is HealthEquity Stock a Hold Now Amid Strong Top-Line Growth?

HQY's sustained strength in HSAs raises optimism about the stock.